Delmar Pharma (DMPI), Accurexa Enter Brain Cancer Therapy-Focused Collaboration
Tweet Send to a Friend
DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) and Accurexa Inc. (OTC: ACXA) announced a collaboration to develop a novel formulation for the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
